Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

  • Product Code:
    RP-ID-10346709
  • Published Date:
    5 Jan 2021
  • Region:
    Global
  • Pages:
    112
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-26

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Asia Pacific pharmaceutical CRO market will grow by 9.6% annually with a total addressable market cap of $238.7 billion over 2020-2030 owing to the rising incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 33 tables and 44 figures, this 112-page report “Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services

Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific pharmaceutical CRO market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK Asia Pacific Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Asia Pacific Market by Service 41
3.1 Market Overview by Service 41
3.2 CRO for Pre-clinical Development 43
3.3 CRO for Phase I Trials 44
3.4 CRO for Phase II Trials 45
3.5 CRO for Phase III Trials 46
3.6 CRO for Phase IV Trials 47
3.7 Laboratory Services 48
3.8 Consulting Services 49
3.9 Data Management Services 50
4 Segmentation of Asia Pacific Market by Therapeutic Application 51
4.1 Market Overview by Therapeutic Application 51
4.2 Infectious Diseases 53
4.3 Oncology 54
4.4 Metabolic Disorders 55
4.5 Cardiovascular Disorders 56
4.6 Central Nervous System 57
4.7 Respiratory Disorders 58
4.8 Gastrointestinal Disorders 59
4.9 Other Therapeutic Applications 60
5 Segmentation of Asia Pacific Market by End User 61
5.1 Market Overview by End User 61
5.2 Pharmaceutical & Biopharmaceutical Companies 63
5.3 Medical Device Companies 64
5.4 Academic Institutes 65
6 Asia-Pacific Market 2019-2030 by Country 67
6.1 Overview of Asia-Pacific Market 67
6.2 Japan 70
6.3 China 73
6.4 Australia 75
6.5 India 77
6.6 South Korea 80
6.7 Rest of APAC Region 82
7 Competitive Landscape 84
7.1 Overview of Key Vendors 84
7.2 New Product Launch, Partnership, Investment, and M&A 88
7.3 Company Profiles 89
Charles River Laboratories 89
CMIC Co. Ltd 91
Covance Inc. 92
Hangzhou Tigermed Consulting Co Ltd 93
ICON Plc 94
IQVIA Holdings Inc. 95
LSK Asia Pacific Pharma Service Co Ltd 96
Novotech Pty Ltd 97
PAREXEL International Corporation 98
Pharmaceutical Product Development LLC (PPD) 99
PRA Health Sciences Inc. 100
Quanticate Ltd 101
Samsung Bioepis Co. Ltd 102
SGS SA (SGS Life Sciences) 103
Syneos Health Inc. 104
WuXi AppTec Inc. 105
8 Investing in Asia Pacific Market: Risk Assessment and Management 106
8.1 Risk Evaluation of Asia Pacific Market 106
8.2 Critical Success Factors (CSFs) 109
Related Reports and Products 112Table 1. Snapshot of Asia Pacific Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World Real GDP, 2017-2021 21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. Worldwide Total Number of Registered Clinical Trials 29
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical CRO Market 33
Table 6. Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, $ bn 41
Table 7. Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 51
Table 8. Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, $ bn 61
Table 9. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn 68
Table 10. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn 72
Table 11. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 72
Table 12. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn 72
Table 13. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn 74
Table 14. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 74
Table 15. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn 74
Table 16. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 76
Table 17. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 76
Table 18. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 76
Table 19. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn 79
Table 20. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 79
Table 21. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn 79
Table 22. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn 81
Table 23. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 81
Table 24. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn 81
Table 25. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn 83
Table 26. Breakdown of Asia Pacific Market by Key Vendor, 2019, % 86
Table 27. Charles River Laboratories: Company Snapshot 89
Table 28. Charles River Laboratories: Business Segmentation 89
Table 29. Charles River Laboratories: Product Portfolio 90
Table 30. Charles River Laboratories: Revenue, 2016-2018, $ bn 90
Table 31. Charles River Laboratories: Recent Developments 90
Table 32. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 107
Table 33. Critical Success Factors and Key Takeaways 110
Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 5. Asia Pacific Pharmaceutical CRO Market, 2019-2030, $ bn 19
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical CRO Market 25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical CRO Market 30
Figure 9. Investment Opportunity Analysis 34
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical CRO Market 37
Figure 11. Breakdown of Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 42
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%) 42
Figure 13. Asia Pacific Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 43
Figure 14. Asia Pacific Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 44
Figure 15. Asia Pacific Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 45
Figure 16. Asia Pacific Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 46
Figure 17. Asia Pacific Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 47
Figure 18. Asia Pacific Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 48
Figure 19. Asia Pacific Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 49
Figure 20. Asia Pacific Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 50
Figure 21. Breakdown of Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 52
Figure 22. Asia Pacific Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%) 52
Figure 23. Asia Pacific Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 53
Figure 24. Asia Pacific Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 54
Figure 25. Asia Pacific Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 55
Figure 26. Asia Pacific Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 56
Figure 27. Asia Pacific Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 57
Figure 28. Asia Pacific Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 58
Figure 29. Asia Pacific Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 59
Figure 30. Asia Pacific Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 60
Figure 31. Breakdown of Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 62
Figure 32. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%) 62
Figure 33. Asia Pacific Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 63
Figure 34. Asia Pacific Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 64
Figure 35. Asia Pacific Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 65
Figure 36. Breakdown of APAC Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue 68
Figure 37. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 69
Figure 38. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn 71
Figure 39. Pharmaceutical CRO Market in China, 2019-2030, $ bn 73
Figure 40. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn 75
Figure 41. Pharmaceutical CRO Market in India, 2019-2030, $ bn 77
Figure 42. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn 80
Figure 43. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn 82
Figure 44. Growth Stage of Asia Pacific Pharmaceutical CRO Industry over the Forecast Period 84
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports